Approach Artery Chemotherapy Dose on Primary Hepatic Cancer with Abnormal Liver Functions
- VernacularTitle:肝功异常的原发性肝癌动脉化疗剂量探讨
- Author:
Hui CHEN
;
Renjie YANG
- Publication Type:Journal Article
- Keywords:
primary liver cancer;
artery chemotherapy;
hepatic function;
dose
- From:
Journal of Practical Radiology
2001;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To find out how to choose the doses of hepatic artery chemotherapy(HAC)in hepatic cell carcinoma(HCC) cases with abnormal liver function.Methods There were 80 HCC patients with one or more liver function index(ALT,AST,TB,DB)above at least 2 times normal,who underwent 105 times HAC or hepatic artery chemoembolization(HACE) with routine chemotherapy doses,and their pre-and postoperative liver and kidney functions had been observing by the end of three weeks after HAC or HACE.Results 1.Postoperative ALT and AST took a favorable turn in preoperative ALT ≥80 U/L group(44 cases)(?
